De Wispelaere, W.; Annibali, D.; Tuyaerts, S.; Lambrechts, D.; Amant, F.
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types? Cancers 2021, 13, 2040.
https://doi.org/10.3390/cancers13092040
AMA Style
De Wispelaere W, Annibali D, Tuyaerts S, Lambrechts D, Amant F.
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types? Cancers. 2021; 13(9):2040.
https://doi.org/10.3390/cancers13092040
Chicago/Turabian Style
De Wispelaere, Wout, Daniela Annibali, Sandra Tuyaerts, Diether Lambrechts, and Frédéric Amant.
2021. "Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?" Cancers 13, no. 9: 2040.
https://doi.org/10.3390/cancers13092040
APA Style
De Wispelaere, W., Annibali, D., Tuyaerts, S., Lambrechts, D., & Amant, F.
(2021). Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types? Cancers, 13(9), 2040.
https://doi.org/10.3390/cancers13092040